132 related articles for article (PubMed ID: 19358571)
1. The orally active antihyperglycemic drug beta-guanidinopropionic acid is transported by the human proton-coupled amino acid transporter hPAT1.
Metzner L; Dorn M; Markwardt F; Brandsch M
Mol Pharm; 2009; 6(3):1006-11. PubMed ID: 19358571
[TBL] [Abstract][Full Text] [Related]
2. Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
Metzner L; Kalbitz J; Brandsch M
J Pharmacol Exp Ther; 2004 Apr; 309(1):28-35. PubMed ID: 14718599
[TBL] [Abstract][Full Text] [Related]
3. Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1).
Voigt V; Laug L; Zebisch K; Thondorf I; Markwardt F; Brandsch M
J Pharm Pharmacol; 2013 Apr; 65(4):582-90. PubMed ID: 23488788
[TBL] [Abstract][Full Text] [Related]
4. Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells.
Larsen M; Larsen BB; Frølund B; Nielsen CU
Eur J Pharm Sci; 2008 Sep; 35(1-2):86-95. PubMed ID: 18621125
[TBL] [Abstract][Full Text] [Related]
5. Influence of a proton gradient on the transport kinetics of the H+/amino acid cotransporter PAT1 in Caco-2 cells.
Metzner L; Brandsch M
Eur J Pharm Biopharm; 2006 Jul; 63(3):360-4. PubMed ID: 16531028
[TBL] [Abstract][Full Text] [Related]
6. Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1).
Anderson CM; Thwaites DT
J Cell Physiol; 2005 Aug; 204(2):604-13. PubMed ID: 15754324
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
Abbot EL; Grenade DS; Kennedy DJ; Gatfield KM; Thwaites DT
Br J Pharmacol; 2006 Feb; 147(3):298-306. PubMed ID: 16331283
[TBL] [Abstract][Full Text] [Related]
8. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxy-L-tryptophan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination.
Larsen M; Holm R; Jensen KG; Sveigaard C; Brodin B; Nielsen CU
Eur J Pharm Sci; 2010 Jan; 39(1-3):68-75. PubMed ID: 19900542
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity of the amino acid transporter PAT1.
Metzner L; Neubert K; Brandsch M
Amino Acids; 2006 Sep; 31(2):111-7. PubMed ID: 16699824
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).
Thondorf I; Voigt V; Schäfer S; Gebauer S; Zebisch K; Laug L; Brandsch M
Bioorg Med Chem; 2011 Nov; 19(21):6409-18. PubMed ID: 21955456
[TBL] [Abstract][Full Text] [Related]
12. Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2.
Chen Z; Fei YJ; Anderson CM; Wake KA; Miyauchi S; Huang W; Thwaites DT; Ganapathy V
J Physiol; 2003 Jan; 546(Pt 2):349-61. PubMed ID: 12527723
[TBL] [Abstract][Full Text] [Related]
13. A novel bifunctionality: PAT1 and PAT2 mediate electrogenic proton/amino acid and electroneutral proton/fatty acid symport.
Foltz M; Boll M; Raschka L; Kottra G; Daniel H
FASEB J; 2004 Nov; 18(14):1758-60. PubMed ID: 15345686
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2).
Kennedy DJ; Gatfield KM; Winpenny JP; Ganapathy V; Thwaites DT
Br J Pharmacol; 2005 Jan; 144(1):28-41. PubMed ID: 15644866
[TBL] [Abstract][Full Text] [Related]
15. Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers.
Nielsen CU; Carstensen M; Brodin B
Eur J Pharm Biopharm; 2012 Jun; 81(2):458-62. PubMed ID: 22452873
[TBL] [Abstract][Full Text] [Related]
16. Function and expression of the proton-coupled amino acid transporter PAT1 along the rat gastrointestinal tract: implications for intestinal absorption of gaboxadol.
Broberg Ml; Holm R; Tønsberg H; Frølund S; Ewon KB; Nielsen Al; Brodin B; Jensen A; Kall MA; Christensen KV; Nielsen CU
Br J Pharmacol; 2012 Oct; 167(3):654-65. PubMed ID: 22577815
[TBL] [Abstract][Full Text] [Related]
17. Substrate recognition by the mammalian proton-dependent amino acid transporter PAT1.
Boll M; Foltz M; Anderson CM; Oechsler C; Kottra G; Thwaites DT; Daniel H
Mol Membr Biol; 2003; 20(3):261-9. PubMed ID: 12893527
[TBL] [Abstract][Full Text] [Related]
18. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
19. Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1.
Metzner L; Kottra G; Neubert K; Daniel H; Brandsch M
FASEB J; 2005 Sep; 19(11):1468-73. PubMed ID: 16126914
[TBL] [Abstract][Full Text] [Related]
20. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.
Nielsen CU; Frølund S; Abdulhadi S; Sari H; Langthaler L; Nøhr MK; Kall MA; Brodin B; Holm R
Br J Pharmacol; 2013 Nov; 170(5):1041-52. PubMed ID: 23962042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
